`

Portola Pharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Biotechnology / pharmaceutical
Thrombosis
And oncology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$258.75M
size-icon Size
51 - 200

Frequently Asked Questions About Portola Pharmaceuticals

What does Portola pharmaceuticals do?+

We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Companys first two commercialized products are Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya (andexanet alfa), and Bevyxxa (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers. We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines

What are Portola pharmaceuticals's specialties? +

Biotechnology / pharmaceutical,thrombosis,and oncology

What is Portola pharmaceuticals's industry? +

Portola pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Portola pharmaceuticals's revenue? +

Portola pharmaceuticals's revenue is 11m - 100m

What is Portola pharmaceuticals's company size? +

Portola pharmaceuticals has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.